Radiopharmaceutical Chemistry and Biology Lab

Focus

Our program focuses on the development of novel probes for use with the molecular imaging technique, positron emission tomography (PET). We apply basic principles of medicinal chemistry and structural biology to design and optimize probes for preclinical and translational imaging studies. Current research focuses mostly on radiotracers for imaging PARP-1 expression in tumors ([18F]FTT), cell proliferation and quiescence ([18F]ISO-1) oxidative stress ([18F]ROStrace), dopamine receptor dysregulation, and abnormal protein aggregation in neurodegenerative disorders such as alpha synuclein in Parkinson’s disease.

Imaging of PARP-1 expression in tumors

Leadership

Laboratory details